Company news
NovoCure Limited news in 2020
NovoCure Limited's news releases, calls and decks from 2020, newest first.
Novocure to Participate in the 39th Annual J.P. Morgan Virtual Healthcare Conference
December 22, 2020
Novocure Announces National Reimbursement in Switzerland for Optune® in Combination With Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
December 13, 2020
First Patient Enrolled in Novocure’s Global Phase 3 TRIDENT Trial of Optune® Concurrent with Radiation Therapy in Newly Diagnosed Glioblastoma
December 9, 2020
Novocure to Participate in the Evercore ISI 2020 Virtual HealthCONx Conference
November 24, 2020
Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting
November 18, 2020
Novocure Receives CE Mark for NovoTTF-100L™ System
November 10, 2020
Novocure Announces Agenda for Virtual Research and Development Day
November 9, 2020
Novocure Announces Closing of $150 Million Revolving Credit Facility with a Syndicate of Relationship Banks
November 8, 2020
Novocure Announces Closing of $575 Million 0% Convertible Senior Notes Private Placement
November 4, 2020
Novocure Prices $500 Million 0% Convertible Senior Notes Private Placement
November 1, 2020
Novocure Announces Proposed Private Placement of $500 Million of Convertible Senior Notes
November 1, 2020
Novocure Reports Third Quarter 2020 Financial Results and Provides Company Update
October 28, 2020
Novocure Announces Strategic Alliance with NYU Grossman School of Medicine for Preclinical and Clinical Research
October 28, 2020
Novocure to Report Third Quarter 2020 Financial Results
October 1, 2020
Novocure to Host Virtual Research & Development Day
September 28, 2020
Novocure Honors Mesothelioma Day with Activities to Raise Awareness of Mesothelioma and Support the Community
September 24, 2020
Novocure to Participate in the 2020 Wells Fargo Virtual Healthcare Conference
September 3, 2020
Novocure Announces Expansion of Its Executive Leadership Team
August 12, 2020
Novocure Reports Second Quarter 2020 Financial Results and Provides Company Update
July 29, 2020
Novocure Announces Recipients of 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
July 27, 2020
First Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays
July 21, 2020
Novocure Announces Clinical Trial Collaboration with MSD to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Non-Small Cell Lung Cancer
July 14, 2020
Novocure Announces Over 100 Physicians in the U.S. Now Certified to Prescribe Optune Lua™
July 7, 2020
Novocure Enrolls Last Patient in HEPANOVA Trial Testing Tumor Treating Fields in Combination with Sorafenib in Advanced Liver Cancer
July 6, 2020